Biocryst Pharmaceuticals reported $273.77M in Current Assets for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Chemocentryx CCXI:US $ 317.13M 73.51M
Chugai Pharma 4519:JP Y 857123M 116152M
Daiichi Sankyo 4568:JP Y 1233697M 34723M
Enanta Pharmaceuticals ENTA:US $ 321.15M 107.06M
Gilead Sciences GILD:US $ 14498M 1220M
GlaxoSmithKline GSK:LN 17.57B 958M
Glaxosmithkline GSK:US $ 17566M 958M
Intra Cellular Therapies ITCI:US $ 601.3M 47.8M
IONIS PHARMACEUT IONS:US $ 2238.42M 249M
Karyopharm Therapeutics KPTI:US $ 273.5M 17.99M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Neurocrine Biosciences NBIX:US $ 1110.1M 24.7M
Novavax NVAX:US $ 2354.99M 108.21M
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M
Zogenix ZGNX:US $ 416.39M 38.34M